Antibody drug conjugates
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Antibody drug conjugates
May 16, 2024, 09:40 |
Blog
Yale Cancer Center - Dr. Patricia LoRusso will be presenting at ESMO Breast
Yale Cancer Center shared a post on X: "Thursday at 9:10am EST, Dr. Patricia LoRusso will…
May 13, 2024, 14:12 |
Blog
Raffaele Colombo: Personal selection of 30 new ADCs that will be presented at ASCO24
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: "Personal selection of…
May 6, 2024, 19:10 |
Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
Apr 29, 2024, 20:00 |
Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 29, 2024, 10:43 |
Blog
Stephanie Graff: Getting excited for ASCO24. Abstract titles are officially out
Stephanie Graff shared a post on X: "Getting excited for ASCO24 Annual Meeting. Abstract titles are…
Apr 26, 2024, 17:44 |
Drugs
Paolo Tarantino: The agnostic potential of Antibody Drug Conjugates with Roberto Carmagnani Pestana, MD is among the most cited of 2022-2023 on CA - A Cancer Journal for Clinicians
Apr 26, 2024, 11:05 |
Blog
Paolo Tarantino: Wonderful experience to brainstorm about the agnostic potential of ADCs with Roberto Carmagnani Pestana
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared a post by Roberto Carmagnani Pestana,…
Apr 13, 2024, 14:18 |
Insight
Jonathan Cohen discusses hepatocellular carcinoma at the annual meeting of the Israeli Oncology Society
Jonathan Cohen, Director of Clinical Research at Sharett Institute of Oncology of Hadassah Medical Center,…
Apr 11, 2024, 08:13 |
Drugs
Tom Powles: Disitimab, Vedotin and Pembrolizumab vs chemotherapy with or without Avelumab in advanced Urothelial Carcinoma
Tom Powles, Director of Barts Cancer Center, recently shared on X: “Trial in progress: The…
Mar 16, 2024, 15:30 |
Blog
Narjust Florez: I spy a visitor in the thoracic oncology hallway Dr. Paolo Tarantino
Quoting Narjust Florez on X/Twitter: "I spy a visitor in the thoracic oncology hallway Dr.…
1
2
All:
17
Posts:
1 - 10
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
Facebook
RSS Feed
Twitter
Linkedin
Youtube